ADMET Property Prediction: The State of the Art and Current Challenges

In this article, we review recent developments in the prediction of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) properties by Quantitative Structure - Activity Relationships (QSAR). We consider advances in statistical modelling techniques, molecular descriptors and the sets of data used for model building and changes in the way in which predictive ADMET models are being applied in drug discovery. We also discuss the current challenges that remain to be addressed. While there has been progress in the adoption of non-linear modelling techniques such as Support Vector Machines (SVM) and Bayesian Neural Networks (BNNs), the full advantages of these 'machine learning' techniques cannot be realised without further developments in molecular descriptors and availability of large, high-quality datasets. The largest pharmaceutical companies have developed large in-house databases containing consistently measured compound properties. However, these data are not yet available in the public domain and many models are still based on small 'historical' datasets taken from the literature. Probably, the largest remaining challenge is the full integration of predictive ADMET modelling in the drug discovery process. Until in silico models are applied to make effective decisions in a multi-parameter optimisation process, the full value they could bring will not be realised.

[1]  Frank R. Burden,et al.  Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks , 2000, J. Chem. Inf. Comput. Sci..

[2]  Li Xing,et al.  Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. , 2004, Journal of medicinal chemistry.

[3]  Brian B. Goldman,et al.  A model for identifying HERG K+ channel blockers. , 2004, Bioorganic & medicinal chemistry.

[4]  Gisbert Schneider,et al.  A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries , 2002, Chembiochem : a European journal of chemical biology.

[5]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[6]  Gabriele Cruciani,et al.  Predictive models for hERG potassium channel blockers. , 2005, Bioorganic & medicinal chemistry letters.

[7]  M H Tarbit,et al.  High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. , 1998, Current opinion in chemical biology.

[8]  William B. Langdon,et al.  Advances in the Application of Machine Learning Techniques in Drug Discovery, Design and Development , 2006 .

[9]  Pierre Bruneau,et al.  Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets , 2001, J. Chem. Inf. Comput. Sci..

[10]  Lemont B. Kier,et al.  Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..

[11]  Michael H. Abraham,et al.  Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .

[12]  Andreas Zell,et al.  Feature Selection for Descriptor Based Classification Models. 2. Human Intestinal Absorption (HIA) , 2004, J. Chem. Inf. Model..

[13]  Gonzalo Colmenarejo,et al.  In Silico ADME Prediction: Data Sets and Models , 2005 .

[14]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[15]  Ting Wang,et al.  Boosting: An Ensemble Learning Tool for Compound Classification and QSAR Modeling , 2005, J. Chem. Inf. Model..

[16]  Sean Ekins,et al.  In silico ADME/Tox: the state of the art. , 2002, Journal of molecular graphics & modelling.

[17]  Geoffrey E. Hinton,et al.  Bayesian Learning for Neural Networks , 1995 .

[18]  Roy J. Vaz,et al.  Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. , 2003, Bioorganic & medicinal chemistry letters.

[19]  Andrew M Davis,et al.  Predictive ADMET studies, the challenges and the opportunities. , 2004, Current opinion in chemical biology.

[20]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[21]  Matthew Segall,et al.  In silico prediction of ADME properties: are we making progress? , 2004, Current opinion in drug discovery & development.

[22]  Peter Gedeck,et al.  Computational Chemistry at Novartis , 2005 .

[23]  F. Burden,et al.  Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.

[24]  D. Agrafiotis,et al.  Variable selection for QSAR by artificial ant colony systems , 2002, SAR and QSAR in environmental research.

[25]  David Hartsough,et al.  Toward an Optimal Procedure for Variable Selection and QSAR Model Building , 2001, J. Chem. Inf. Comput. Sci..

[26]  Frank R. Burden,et al.  Quantitative Structure-Activity Relationship Studies Using Gaussian Processes , 2001, J. Chem. Inf. Comput. Sci..

[27]  Joelle M. R. Gola,et al.  Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery , 2006, Expert opinion on drug metabolism & toxicology.

[28]  A. Cavalli,et al.  Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. , 2002, Journal of medicinal chemistry.

[29]  Dimitris K Agrafiotis,et al.  A QSAR Model of hERG Binding Using a Large, Diverse, and Internally Consistent Training Set , 2006, Chemical biology & drug design.

[30]  S. O'Brien,et al.  Greater than the sum of its parts: combining models for useful ADMET prediction. , 2005, Journal of medicinal chemistry.

[31]  Matthew Clark,et al.  Development and Evaluation of an in Silico Model for hERG Binding , 2006, J. Chem. Inf. Model..

[32]  G. Keserü.  Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. , 2003, Bioorganic & medicinal chemistry letters.

[33]  Meihua Tu,et al.  Development of a computational approach to predict blood-brain barrier permeability. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[34]  W. Crumb,et al.  Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. , 2002, The Journal of pharmacology and experimental therapeutics.

[35]  Marina Lasagni,et al.  New molecular descriptors for 2D and 3D structures. Theory , 1994 .

[36]  D. E. Clark.  Computational Prediction of Blood-brain Barrier Permeation , 2005 .

[37]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[38]  M. Tarbit,et al.  Discovery of fluconazole, a novel antifungal agent. , 1990, Reviews of infectious diseases.

[39]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[40]  Ling Yang,et al.  Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach , 2005, J. Chem. Inf. Model..

[41]  David E. Leahy,et al.  Automated QSPR through Competitive Workflow , 2005, J. Comput. Aided Mol. Des..

[42]  Y. Martin,et al.  A bioavailability score. , 2005, Journal of medicinal chemistry.